Managing vesicoureteral reflux in children

Making sense of all the data [version 1; referees: 2 approved]

Angelena Edwards, Craig A Peters

Research output: Contribution to journalReview article

Abstract

Current management of vesicoureteral reflux (VUR) in children is the result of a steady albeit controversial evolution of data and thinking related to the clinical impact of VUR and urinary tract infection (UTI) in children, the value of clinical screening, and the relative impact of testing and interventions for VUR. While controversy continues, there is consensus on the importance of bladder dysfunction on VUR outcomes, the likelihood of VUR resolution, and the fact that not all children with VUR require active treatment. Early efforts to define risk stratification hold the most promise to provide more patient-specific treatment of UTI and VUR in children.

Original languageEnglish (US)
Article number29
JournalF1000Research
Volume8
DOIs
StatePublished - Jan 1 2019

Fingerprint

Vesico-Ureteral Reflux
Screening
Testing
Urinary Tract Infections
Urinary Bladder
Therapeutics

Keywords

  • Antibiotic prophylaxis
  • Pediatric Vesicoureteral Reflux
  • Renal scarring
  • Urinary tract infection

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Managing vesicoureteral reflux in children : Making sense of all the data [version 1; referees: 2 approved]. / Edwards, Angelena; Peters, Craig A.

In: F1000Research, Vol. 8, 29, 01.01.2019.

Research output: Contribution to journalReview article

@article{2a907aa4e4ae47d5a05d6fae733c0dc1,
title = "Managing vesicoureteral reflux in children: Making sense of all the data [version 1; referees: 2 approved]",
abstract = "Current management of vesicoureteral reflux (VUR) in children is the result of a steady albeit controversial evolution of data and thinking related to the clinical impact of VUR and urinary tract infection (UTI) in children, the value of clinical screening, and the relative impact of testing and interventions for VUR. While controversy continues, there is consensus on the importance of bladder dysfunction on VUR outcomes, the likelihood of VUR resolution, and the fact that not all children with VUR require active treatment. Early efforts to define risk stratification hold the most promise to provide more patient-specific treatment of UTI and VUR in children.",
keywords = "Antibiotic prophylaxis, Pediatric Vesicoureteral Reflux, Renal scarring, Urinary tract infection",
author = "Angelena Edwards and Peters, {Craig A}",
year = "2019",
month = "1",
day = "1",
doi = "10.12688/f1000research.16534.1",
language = "English (US)",
volume = "8",
journal = "F1000Research",
issn = "2046-1402",
publisher = "F1000 Research Ltd.",

}

TY - JOUR

T1 - Managing vesicoureteral reflux in children

T2 - Making sense of all the data [version 1; referees: 2 approved]

AU - Edwards, Angelena

AU - Peters, Craig A

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Current management of vesicoureteral reflux (VUR) in children is the result of a steady albeit controversial evolution of data and thinking related to the clinical impact of VUR and urinary tract infection (UTI) in children, the value of clinical screening, and the relative impact of testing and interventions for VUR. While controversy continues, there is consensus on the importance of bladder dysfunction on VUR outcomes, the likelihood of VUR resolution, and the fact that not all children with VUR require active treatment. Early efforts to define risk stratification hold the most promise to provide more patient-specific treatment of UTI and VUR in children.

AB - Current management of vesicoureteral reflux (VUR) in children is the result of a steady albeit controversial evolution of data and thinking related to the clinical impact of VUR and urinary tract infection (UTI) in children, the value of clinical screening, and the relative impact of testing and interventions for VUR. While controversy continues, there is consensus on the importance of bladder dysfunction on VUR outcomes, the likelihood of VUR resolution, and the fact that not all children with VUR require active treatment. Early efforts to define risk stratification hold the most promise to provide more patient-specific treatment of UTI and VUR in children.

KW - Antibiotic prophylaxis

KW - Pediatric Vesicoureteral Reflux

KW - Renal scarring

KW - Urinary tract infection

UR - http://www.scopus.com/inward/record.url?scp=85060029275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060029275&partnerID=8YFLogxK

U2 - 10.12688/f1000research.16534.1

DO - 10.12688/f1000research.16534.1

M3 - Review article

VL - 8

JO - F1000Research

JF - F1000Research

SN - 2046-1402

M1 - 29

ER -